Conversely, the level of PINK1 was found to be significantly reduced (approximately 35%) or nearly unchanged in IF1-silenced cells derived from osteosarcoma and colon carcinoma, respectively (Figure 5). This evidence concerns the gene PINK1 and osteosarcoma.